Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 2 records, 1 pages
Search For: Anti-amyloid Therapy
Global Anti-amyloid Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
27 Oct 2024
Pharma & Healthcare
Anti-amyloid therapy refers to a treatment approach aimed at addressing Alzheimer's disease by targeting and reducing the accumulation of amyloid-beta plaques in the brain. These therapies are designed to modify the disease's progression rather than merely alleviate symptoms. By utilizing agents that bind to amyloid-beta or promote its clearance, anti-amyloid therapies seek to improve cognitive function and slow neurodegeneration in affected individuals. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.
USD3480.00
Add To Cart
Global Anti-amyloid Therapy Supply, Demand and Key Producers, 2024-2030
27 Oct 2024
Pharma & Healthcare
Anti-amyloid therapy refers to a treatment approach aimed at addressing Alzheimer's disease by targeting and reducing the accumulation of amyloid-beta plaques in the brain. These therapies are designed to modify the disease's progression rather than merely alleviate symptoms. By utilizing agents that bind to amyloid-beta or promote its clearance, anti-amyloid therapies seek to improve cognitive function and slow neurodegeneration in affected individuals. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
Search For: Anti-amyloid Therapy
Total: 2 records, 1 pages
Anti-amyloid therapy refers to a treatment approach aimed at addressing Alzheimer's disease by targeting and reducing the accumulation of amyloid-beta plaques in the brain. These therapies are designed to modify the disease's progression rather than merely alleviate symptoms. By utilizing agents that bind to amyloid-beta or promote its clearance, anti-amyloid therapies seek to improve cognitive function and slow neurodegeneration in affected individuals. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.
USD3480.00
Add To Cart
Anti-amyloid therapy refers to a treatment approach aimed at addressing Alzheimer's disease by targeting and reducing the accumulation of amyloid-beta plaques in the brain. These therapies are designed to modify the disease's progression rather than merely alleviate symptoms. By utilizing agents that bind to amyloid-beta or promote its clearance, anti-amyloid therapies seek to improve cognitive function and slow neurodegeneration in affected individuals. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>